日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Long-term data from a phase 3 study of radotinib versus imatinib in patients with newly diagnosed, chronic myeloid leukaemia in the chronic phase (RERISE)

一项针对新诊断的慢性期慢性粒细胞白血病患者的 3 期研究（RERISE）的长期数据，比较了雷多替尼与伊马替尼的疗效。

期刊:British Journal of Haematology
影响因子:3.8
doi:10.1111/bjh.16381
Do, Young Rok; Kwak, Jae-Yong; Kim, Jeong A; Kim, Hyeoung Joon; Chung, Joo Seop; Shin, Ho-Jin; Kim, Sung-Hyun; Bunworasate, Udomsak; Choi, Chul Won; Zang, Dae Young; Oh, Suk Joong; Jootar, Saengsuree; Reksodiputro, Ary Harryanto; Lee, Won Sik; Mun, Yeung-Chul; Kong, Jee Hyun; Caguioa, Priscilla B; Kim, Hawk; Park, Jinny; Kim, Dong-Wook
白血病
细胞生物学
粒细胞
发表日期：2020
文献求助 收藏

Magnetic Nanoparticles PCR Enzyme-Linked Gene Assay for Quantitative Detection of BCR/ABL Fusion Gene in Chronic Myelogenous Leukemia

用于定量检测慢性粒细胞白血病中 BCR/ABL 融合基因的磁性纳米粒子 PCR 酶联基因检测

期刊:Journal of Clinical Laboratory Analysis
影响因子:2.9
doi:10.1002/jcla.21899
Manthawornsiri, Yanaphat; Polpanich, Duangporn; Yamkamon, Vichanan; Thiramanas, Raweewan; Hongeng, Suradej; Rerkamnuaychoke, Budsaba; Jootar, Saengsuree; Tangboriboonrat, Pramuan; Jangpatarapongsa, Kulachart
BCR
细胞生物学
白血病
粒细胞
发表日期：2016
文献求助 收藏

Efficacy and safety of radotinib in chronic phase chronic myeloid leukemia patients with resistance or intolerance to BCR-ABL1 tyrosine kinase inhibitors

雷多替尼治疗对 BCR-ABL1 酪氨酸激酶抑制剂耐药或不耐受的慢性期慢性粒细胞白血病患者的疗效和安全性

期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2013.096776
Kim, Sung-Hyun; Menon, Hari; Jootar, Saengsuree; Saikia, Tapan; Kwak, Jae-Yong; Sohn, Sang-Kyun; Park, Joon Seong; Jeong, Seong Hyun; Kim, Hyeoung Joon; Kim, Yeo-Kyeoung; Oh, Suk Joong; Kim, Hawk; Zang, Dae Young; Chung, Joo Seop; Shin, Ho Jin; Do, Young Rok; Kim, Jeong-A; Kim, Dae-Young; Choi, Chul Won; Park, Sahee; Park, Hye Lin; Lee, Gong Yeal; Cho, Dae Jin; Shin, Jae Soo; Kim, Dong-Wook
信号转导
ABL1
粒细胞
白血病
BCR
细胞生物学
发表日期：2014
文献求助 收藏

Treatment outcome of thalidomide based regimens in newly diagnosed and relapsed/refractory non-transplant multiple myeloma patients: a single center experience from Thailand

沙利度胺方案治疗新诊断和复发/难治性非移植性多发性骨髓瘤患者的疗效：泰国单中心经验

期刊:Journal of Hematology & Oncology
影响因子:40.4
doi:10.1186/1756-8722-3-1
Niparuck, Pimjai; Sorakhunpipitkul, Ladda; Atichartakarn, Vichai; Chuncharunee, Suporn; Ungkanont, Artit; Aungchaisuksiri, Pantep; Puavilai, Teeraya; Jootar, Saengsuree
多发性骨髓瘤
骨髓瘤
发表日期：2010
文献求助 收藏